Fortrea (FTRE) Projected to Post Quarterly Earnings on Tuesday

Fortrea (NASDAQ:FTRE) is expected to be announcing its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $631.3290 million for the quarter. Individuals may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Tuesday, May 5, 2026 at 8:00 AM ET.

Fortrea (NASDAQ:FTRE) last released its quarterly earnings results on Thursday, February 26th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.07). Fortrea had a negative net margin of 36.21% and a positive return on equity of 6.23%. The company had revenue of $660.50 million for the quarter, compared to analysts’ expectations of $665.22 million. On average, analysts expect Fortrea to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Fortrea Trading Up 1.7%

NASDAQ:FTRE traded up $0.18 during midday trading on Tuesday, hitting $10.78. 758,179 shares of the company traded hands, compared to its average volume of 1,512,728. Fortrea has a 12-month low of $3.97 and a 12-month high of $18.67. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 1.86. The firm’s fifty day moving average is $9.84 and its 200-day moving average is $12.44. The firm has a market capitalization of $1.01 billion, a P/E ratio of -0.99, a P/E/G ratio of 0.36 and a beta of 1.80.

Insider Activity

In related news, CFO Jill G. Mcconnell sold 5,061 shares of the company’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $9.07, for a total value of $45,903.27. Following the transaction, the chief financial officer directly owned 69,796 shares of the company’s stock, valued at $633,049.72. This represents a 6.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last 90 days, insiders sold 9,673 shares of company stock valued at $92,242. 0.38% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Osaic Holdings Inc. increased its holdings in shares of Fortrea by 74.3% in the second quarter. Osaic Holdings Inc. now owns 6,844 shares of the company’s stock valued at $38,000 after purchasing an additional 2,918 shares during the period. Tower Research Capital LLC TRC increased its holdings in shares of Fortrea by 137.0% in the second quarter. Tower Research Capital LLC TRC now owns 8,713 shares of the company’s stock valued at $43,000 after purchasing an additional 5,036 shares during the period. Toronto Dominion Bank acquired a new position in shares of Fortrea in the fourth quarter valued at about $51,000. EverSource Wealth Advisors LLC increased its holdings in shares of Fortrea by 662.9% in the second quarter. EverSource Wealth Advisors LLC now owns 11,963 shares of the company’s stock valued at $59,000 after purchasing an additional 10,395 shares during the period. Finally, Franklin Resources Inc. acquired a new position in shares of Fortrea in the second quarter valued at about $60,000.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on FTRE shares. Evercore set a $25.00 price target on shares of Fortrea and gave the stock an “outperform” rating in a research note on Tuesday, January 6th. Mizuho set a $15.00 target price on Fortrea in a research note on Friday, January 9th. TD Cowen upgraded Fortrea from a “hold” rating to a “buy” rating and set a $15.00 target price on the stock in a research note on Monday, March 9th. Weiss Ratings restated a “sell (d-)” rating on shares of Fortrea in a research note on Tuesday, April 21st. Finally, Truist Financial set a $22.00 price objective on Fortrea and gave the company a “buy” rating in a report on Thursday, January 8th. Five investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Fortrea has a consensus rating of “Hold” and an average price target of $16.05.

About Fortrea

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.